|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
2
|
Resverlogix Corp.
|
May 10, 2022 09:28AM
|
|
Update
|
1
|
Resverlogix Corp.
|
Dec 16, 2021 04:55PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
1
|
Resverlogix Corp.
|
Dec 13, 2021 08:42AM
|
|
Re: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.
|
1
|
Zenith Epigenetics
|
Nov 17, 2021 05:33PM
|
|
Good morning
|
3
|
Resverlogix Corp.
|
Sep 07, 2021 09:45AM
|
|
The Worst
|
5
|
Zenith Epigenetics
|
Jul 30, 2021 10:42AM
|
|
There was once value here
|
3
|
Zenith Epigenetics
|
Jul 16, 2021 06:03PM
|
|
Thanks
|
2
|
Resverlogix Corp.
|
May 12, 2021 07:10AM
|
|
Re: Still no trial.....wow
|
4
|
Resverlogix Corp.
|
Apr 30, 2021 12:37PM
|
|
Investment
|
3
|
Resverlogix Corp.
|
Apr 23, 2021 11:35AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
3
|
Resverlogix Corp.
|
Apr 20, 2021 04:01PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
1
|
Resverlogix Corp.
|
Apr 20, 2021 10:20AM
|
|
32 cents
|
4
|
Zenith Epigenetics
|
Mar 18, 2021 03:15PM
|
|
Closing the deal
|
2
|
Resverlogix Corp.
|
Feb 17, 2021 02:59PM
|
|
Re: ZHCLF trading in registered accounts
|
1
|
Zenith Epigenetics
|
Feb 08, 2021 08:56PM
|
|
Re: ZHCLF trading
|
1
|
Zenith Epigenetics
|
Feb 05, 2021 04:35PM
|
|
Re: ZHCLF trading
|
1
|
Zenith Epigenetics
|
Feb 05, 2021 03:07PM
|
|
Re: Financing
|
3
|
Resverlogix Corp.
|
Feb 04, 2021 03:28PM
|
|
Re: insiders going it alone?
|
2
|
Resverlogix Corp.
|
Jan 30, 2021 10:22AM
|
|
Re: insiders going it alone?
|
3
|
Resverlogix Corp.
|
Jan 30, 2021 07:42AM
|
